Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Prospective Observational Study Evaluating the Efficacy and Tolerability of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis

NCT05359315 is registered in ClinicalTrials.gov with SPP Pharmaclon Ltd. as lead sponsor.

NCT NCT05359315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05359315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Prospective Observational Study Evaluating the Efficacy and Tolerability of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis
Lead sponsor
SPP Pharmaclon Ltd.
Phase
Observational
Overall status
Unknown status
Start date
April 15, 2022
Completion date
May 1, 2023
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tuberculosis